Gene · 6304
Papers1,882
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,882
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial Note: Global Regulator SATB1 Recruits β-Catenin and Regulates TH2 Differentiation in Wnt-Dependent Manner. | PLoS Biol | 2025 | 41264553 | PubTator, text mining | PubMed |
| [The Relationship between the Expression of SATB1 and Clinicopathological Features and Prognosis of Diffuse Large B-Cell Lymphoma]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41234083 | PubTator, text mining | PubMed |
| Development and validation of a novel signature to predict the survival and affect the immune microenvironment of esophageal squamous cell carcinoma: epigenetic-related genes. | Front Immunol | 2025 | 41208974 | PubTator, text mining | PubMed |
| An Anoikis-Based Prognostic Signature Identifies MYC as a Key Regulator of Malignancy and Immunotherapy Resistance in Bladder Cancer. | Front Biosci (Landmark Ed) | 2025 | 41198549 | PubTator, text mining | PubMed |
| Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer. | Nat Immunol | 2025 | 41145844 | PubTator, text mining | PubMed |
| Genome organization by SATB1 binding to base-unpairing regions (BURs) provides a scaffold for SATB1-regulated gene expression. | Elife | 2025 | 41036778 | PubTator, text mining | PubMed |
| Exploration of effective biomarkers and infiltrating immune cells in metastatic colorectal cancer based on bioinformatics analysis. | Sci Rep | 2025 | 41006647 | PubTator, text mining | PubMed |
| Tissue-Resident T Cells That Promote Humoral Immunity: Emerging From the Shadow of T Follicular Helper Cells. | Immunol Rev | 2025 | 40890948 | PubTator, text mining | PubMed |
| ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs. | J Exp Clin Cancer Res | 2025 | 40890836 | PubTator, text mining | PubMed |
| Wnt signaling - using the bloodstream to send a message. | Cell Mol Life Sci | 2025 | 40879783 | PubTator, text mining | PubMed |
| EGFR Levels in NSCLC Are Associated With Expression of SATB1 and EMT-promoting Factors. | Anticancer Res | 2025 | 40876994 | PubTator, text mining | PubMed |
| SATB1 is a key regulator of quiescence in stem-like CD8+ T cells. | Nat Immunol | 2025 | 40847243 | PubTator, text mining | PubMed |
| Reconstitution of T cell-mediated immunity by umbilical cord-derived mesenchymal stem cells in ulcerative colitis. | Clin Transl Med | 2025 | 40842289 | PubTator, text mining | PubMed |
| Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer. | Oncotarget | 2025 | 40689929 | PubTator, text mining | PubMed |
| Dysregulation of heterochromatin caused by genomic structural variants may be central to autism spectrum disorder. | Front Mol Neurosci | 2025 | 40612695 | PubTator, text mining | PubMed |
| Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression. | Cell Rep | 2025 | 40531625 | PubTator, text mining | PubMed |
| Identification of the immune-associated enhancer RNA SATB1-AS1 as a novel biomarker for thymic cancer prognosis. | PLoS One | 2025 | 40440611 | PubTator, text mining | PubMed |
| Dibutyl phthalate exposure suppresses Wnt/β-catenin pathway and induces oxidative damage in placenta. | Ecotoxicol Environ Saf | 2025 | 40435784 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| scMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data. | Nat Commun | 2025 | 40341143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6304/papers?page=3